Mason Street Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-23,735
Closed -$3.6M 1219
2020
Q4
$3.6M Sell
23,735
-35
-0.1% -$5.31K 0.06% 348
2020
Q3
$2.4M Sell
23,770
-348
-1% -$35.2K 0.05% 440
2020
Q2
$2.92M Buy
24,118
+778
+3% +$94.1K 0.06% 350
2020
Q1
$2.21M Hold
23,340
0.05% 391
2019
Q4
$2.06M Buy
23,340
+344
+1% +$30.3K 0.04% 580
2019
Q3
$1.83M Sell
22,996
-356
-2% -$28.4K 0.04% 604
2019
Q2
$1.82M Buy
23,352
+102
+0.4% +$7.96K 0.04% 609
2019
Q1
$2.73M Buy
23,250
+419
+2% +$49.2K 0.06% 401
2018
Q4
$2.49M Buy
22,831
+457
+2% +$49.8K 0.06% 355
2018
Q3
$2.86M Buy
22,374
+41
+0.2% +$5.24K 0.06% 366
2018
Q2
$2.53M Buy
22,333
+615
+3% +$69.6K 0.06% 417
2018
Q1
$2.44M Buy
21,718
+429
+2% +$48.2K 0.06% 426
2017
Q4
$3.15M Sell
21,289
-273
-1% -$40.4K 0.07% 316
2017
Q3
$2.53M Sell
21,562
-450
-2% -$52.7K 0.06% 391
2017
Q2
$2.86M Buy
22,012
+771
+4% +$100K 0.07% 320
2017
Q1
$2.88M Buy
21,241
+1,445
+7% +$196K 0.07% 311
2016
Q4
$2.84M Sell
19,796
-316
-2% -$45.3K 0.08% 300
2016
Q3
$2.38M Sell
20,112
-237
-1% -$28K 0.07% 357
2016
Q2
$2.16M Buy
20,349
+602
+3% +$63.8K 0.06% 379
2016
Q1
$2.2M Buy
19,747
+636
+3% +$70.9K 0.07% 350
2015
Q4
$2.99M Buy
19,111
+384
+2% +$60.1K 0.09% 231
2015
Q3
$2.46M Sell
18,727
-7
-0% -$919 0.08% 277
2015
Q2
$3.26M Sell
18,734
-61
-0.3% -$10.6K 0.1% 217
2015
Q1
$3.24M Sell
18,795
-4,964
-21% -$856K 0.1% 220
2014
Q4
$3.08M Sell
23,759
-222
-0.9% -$28.8K 0.02% 759
2014
Q3
$3.09M Buy
23,981
+1,411
+6% +$182K 0.02% 733
2014
Q2
$2M Sell
22,570
-1,239
-5% -$110K 0.02% 956
2014
Q1
$2.24M Buy
23,809
+18
+0.1% +$1.69K 0.02% 892
2013
Q4
$2.69M Sell
23,791
-89
-0.4% -$10.1K 0.02% 790
2013
Q3
$1.88M Sell
23,880
-3,630
-13% -$286K 0.02% 739
2013
Q2
$1.81M Buy
+27,510
New +$1.81M 0.02% 709